Alzheimer disease (AD) and type 2 diabetes mellitus (T2DM) are conditions that affect a
large number of people in the industrialized countries. Both conditions are on the increase,
and finding novel treatments to cure or prevent them are a major aim in research. Somewhat
surprisingly, AD and T2DM share several molecular processes that underlie the respective
degenerative developments. This review describes and discusses several of these shared
biochemical and physiological pathways. Disturbances in insulin signalling appears to be …